3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
4
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Not yet recruiting
2
Completed
2
Sponsor Class
OTHER
31
INDUSTRY
25
OTHER_GOV
4
NIH
2
NETWORK
1
Study Type
Interventional
4
Sponsor
Cancer Type
Dermatologic
4
Conditions
Melanoma
6
Lymphoma, B-Cell
5
Uveal Melanoma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Recurrence
3
Polycystic Ovary Syndrome
3
Neoplasms, Plasma Cell
3
Multiple Myeloma
3
Hematologic Neoplasms
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Follicular
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Interventions
Melphalan
3
Interleukin-2
3
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER_GOV
×
Uveal Melanoma
×
Clear all
NCT04812470
2025-09-22
HAITILS
Vastra Gotaland Region
Phase 1
Completed
8 enrolled
NCT07183852
2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1
Not yet recruiting
18 enrolled
NCT04463368
2025-03-28
SCANDIUM II
Vastra Gotaland Region
Phase 1
Completed
18 enrolled
NCT05903937
2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1
Not yet recruiting
6 enrolled